Drug profile · INN
cyclophosphamide
CYCLONEX
cyclophosphamide (CYCLONEX) is a dna inhibitor. Associated with Amdipharm Mercury (Australia) Pty Limited. Route of administration: solution. Current US regulatory status: approved.
Drug details — cyclophosphamide
- US status
- approved
- Class
- —
- Route
- SOLUTION
- Patents
- 8
- Programs
- 128
- Data quality
- 0.89
Quick answer
cyclophosphamide (CYCLONEX) is a dna inhibitor. Associated with Amdipharm Mercury (Australia) Pty Limited. Route of administration: solution. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11707434
Method for preparing organic solvent-free lyophilized cyclophosphamide
granted -
US 8501678
Variant activin receptor polypeptides and uses thereof
granted -
US 8410043
Stabilized activin IIB receptor polypeptides and uses thereof
granted -
US 8309071
Foamy viral envelope genes
granted -
US 8293803
Retinoid compounds and their use
granted -
US 7183334
Low temperature molding compositions with solid thermoplastic elastomer thickeners and fiber reinforcement
granted -
US 6433037
Method of preparing molding compositions with fiber reinforcement and products obtained therefrom
expired -
US 6103779
Method of preparing molding compositions with fiber reinforcement and products obtained therefrom
expired
Frequently asked questions
What is cyclophosphamide?
cyclophosphamide (CYCLONEX) is a dna inhibitor. Associated with Amdipharm Mercury (Australia) Pty Limited. Route of administration: solution. Current US regulatory status: approved.
What is the brand name for cyclophosphamide?
CYCLONEX is a marketed brand name for cyclophosphamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cyclophosphamide?
cyclophosphamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.